Shree Ganesh Biotech logo

Shree Ganesh Biotech

539470 BSE
₹0.44 0.02 (4.35%)
Market Cap
₹17.50 Cr

Shree Ganesh Biotech (SHREEGANES) share price was ₹0.44 at the 28 Oct 2026 close; market capitalisation ₹17.50 Cr; sector Healthcare. The share price fell 41.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 3.6% year on year to ₹1.43 Cr and net profit was −₹0.57 Cr, against ₹0.33 Cr a year earlier (compared with Jun 2025). Promoters held 0.00% of Shree Ganesh Biotech in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 38/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹0.44 −0.31 −41.33% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹17.50 Cr
EBITDA
₹50.00 L
Return on Equity
0.59%
Debt to Equity
0
Book Value
₹1.60
EPS (TTM)
₹0.00
52W High
₹0.75
52W Low
₹0.44

Price-based figures as of 28 Oct 2026, 16:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Biotechnology

Anthem Biosciences
₹832.1581.1946,894 Cr15.410.24%19.45%26.78%2,161 Cr576 Cr
Advanced Enzyme Tech
₹259.7517.532,887 Cr1.782.05%10.31%13.58%800 Cr172 Cr
CCME Global
₹31.93—144 Cr3.610.00%-0.35%0.87%0 Cr-1 Cr
Shree Ganesh Biotech (this company)
₹0.44—18 Cr0.270.00%0.59%0.81%7 Cr-0 Cr
Genomic Valley Biotech
₹43.631,454.3313 Cr3.400.00%9.13%11.32%0 Cr0 Cr
Median 5 companies₹43.6381.19144 Cr3.400.00%9.13%11.32%7 Cr0 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
38 Weak
Overall score
Data confidence 88/100

Category scores

Quality Poor 28
Returns, margins, earnings quality 22%
Valuation Weak 45
Cheap vs sector & own history 24%
Growth Poor 1
Sales & profit trajectory 9%
Financial Health Good 64
Solvency, leverage, coverage 9%
Momentum Poor 16
Trend strength, vol-adjusted 12%
Ownership Average 50
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.29 times its book value

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -22.0% over past five years.
  • Company has a low return on equity of 0.84% over last 3 years.
  • Working capital days have increased from 260 days to 861 days

Technical Indicators

Oscillators

BearishNeutralBullish

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-73.77% lower than 3Y

change over 1 year

Net Income Growth
33.33% higher than 3Y

change over 1 year

Cash Flow Change
19.69%

change over 1 year

EBITDA Margin Change
403%

change over 1 year Operating margin -62.24% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.25
4.12
4.12
3.78
3.56
1.98
14.41
3.01
1.38
0.77
0.7
2.12
1.43
Expenses
8.1
4.04
4.03
4.3
3.69
1.96
13.94
4.43
1.47
1.17
0.75
2.55
2.32
Operating Profit
0.15
0.08
0.09
-0.52
-0.13
0.02
0.47
-1.42
-0.09
-0.4
-0.05
-0.43
-0.89
OPM %
1.82%
1.94%
2.18%
-13.76%
-3.65%
1.01%
3.26%
-47.18%
-6.52%
-51.95%
-7.14%
-20.28%
-62.24%
Other Income
0
0
0
1.06
0.37
0.3
0.3
0.47
0.42
0.41
0.37
0.28
0.32
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.15
0.08
0.09
0.54
0.24
0.32
0.77
-0.95
0.33
0.01
0.32
-0.15
-0.57
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
0.15
0.08
0.09
0.54
0.24
0.32
0.77
-0.95
0.33
0.01
0.32
-0.15
-0.57
EPS (₹)
0
0
0
0.01
0.01
0.01
0.02
-0.02
0.01
0
0.01
0
-0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1.68
2.12
8.54
7.86
5.87
2.47
17.21
72.64
62.45
20.28
22.96
4.97
5.02
Expenses
1.17
1.47
4.78
4.36
4.08
2.23
16.5
69.19
60.3
20.48
23.92
5.61
6.79
Operating Profit
0.51
0.65
3.76
3.5
1.79
0.24
0.71
3.45
2.15
-0.2
-0.96
-0.64
-1.77
OPM %
30.36%
30.66%
44.03%
44.53%
30.49%
9.72%
4.13%
4.75%
3.44%
-0.99%
-4.18%
-12.88%
-35.26%
Other Income
0
0.04
0
0
0
0
-0.28
0.05
0.56
1.06
1.35
1.15
1.38
Interest
0.07
0.07
0.03
0
0
0
0
0
0
0
0
0
0
Depreciation
0.1
0.07
0
0
0
0
0
0
0
0
0
0
0
PBT
0.34
0.55
3.73
3.5
1.79
0.24
0.43
3.5
2.71
0.86
0.39
0.51
-0.39
Tax %
0%
1.82%
0%
0%
0%
0%
25.58%
27.71%
25.09%
26.74%
28.21%
27.45%
—
Net Profit
0.34
0.54
3.73
3.5
1.79
0.24
0.32
2.53
2.04
0.62
0.28
0.38
-0.39
EPS (₹)
0.09
0.15
1.01
0.95
0.04
0.01
0.01
0.06
0.05
0.02
0.01
0.01
0
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1.83
1.83
1.83
1.83
19.93
19.93
19.93
19.93
39.86
39.86
39.86
39.86
Reserves
2.41
2.94
17.54
21.04
37.31
37.54
37.86
40.39
22.49
23.12
23.39
23.77
Borrowings
0.61
0.5
0.06
0.19
0.19
0.19
0.19
0
0
0
0
0
Other Liabilities
0.12
0.03
0.01
3.3
6.66
7.06
16.64
33.24
17.18
10.64
0.24
0.17
Total Liabilities
4.97
5.3
19.44
26.36
64.09
64.72
74.62
93.56
79.53
73.62
63.49
63.8
Fixed Assets
2.4
2.32
0
0
0.01
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.21
0.21
0
0
0
0
3.06
3.22
0
0
9.15
9.15
Other Assets
2.36
2.77
19.44
26.36
64.08
64.72
71.56
90.34
79.53
73.62
54.34
54.65
Total Assets
4.97
5.3
19.44
26.36
64.09
64.72
74.62
93.56
79.53
73.62
63.49
63.8
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.07
-0.04
-12.94
2.23
-0.5
-1.01
2.36
3.57
10.54
10.16
-10.21
-8.2
Investing
-0.11
0
2.53
-2.36
-32.07
0.99
-2.36
-3.37
-10.09
-10.21
9.8
8.19
Financing
0.28
-0.11
10.42
0.13
32.58
0
0
-0.19
0
0
0
0
Net Cash Flow
0.1
-0.16
0.02
0
0.01
-0.02
0.01
0.01
0.44
-0.05
-0.41
0
Free Cash Flow
-0.07
-0.04
-10.62
2.23
-0.51
-1.01
2.36
3.57
10.54
10.16
-10.21
-8.2
CFO/OP
-14
-6
-344
64
-28
-421
348
132
522
-5,080
1,052
1,259
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
261
456
384
628
1,191
3,072
601
221
113
59.39
0
0
Inventory Days
483
0
0
0
0
0
0
0
0
0
46.59
846
Days Payable
46.27
—
—
—
—
—
—
—
—
—
0
0
Cash Conversion Cycle
698
456
384
628
1,191
3,072
601
221
113
59.39
46.59
846
Working Capital Days
311
381
384
476
779
2,036
249
53.71
12.8
-132
50.08
861
ROCE %
9.04%
12.25%
30.45%
16.47%
4.45%
0.42%
1.23%
5.92%
4.42%
1.37%
0.76%
1.31%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Shree Ganesh Biotech insights

62 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Public95.45%FIIs1.42%Others3.12%As ofSep 2026

Documents

Frequently Asked Questions about Shree Ganesh Biotech

What does Shree Ganesh Biotech India Ltd do?
Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.[1]
Where is Shree Ganesh Biotech India Ltd (SHREEGANES) listed?
Shree Ganesh Biotech India Ltd trades under code 539470 on the BSE.
Which sector does Shree Ganesh Biotech India Ltd belong to?
Shree Ganesh Biotech India Ltd is classified under the Healthcare sector, in the Biotechnology industry.
What is the market capitalisation of Shree Ganesh Biotech India Ltd?
Shree Ganesh Biotech India Ltd has a market capitalisation of ₹17.5 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Shree Ganesh Biotech India Ltd?
Over the last 52 weeks Shree Ganesh Biotech India Ltd has traded between ₹0.44 and ₹0.75 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Shree Ganesh Biotech India Ltd?
Shree Ganesh Biotech India Ltd reported a return on equity of 0.59%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.[1]

Website shreeganeshbiotech.club
Listed 2017-09-22
Face Value ₹ 1
Shares Outstanding 39,78,26,087

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539470.md for Shree Ganesh Biotech India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month